SCHEMBL5159739

SCHEMBL5159739

COc1ccc(-c2c(CN)[nH]c3cc(OC)c(OC)cc23)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.52
MAPT P10636 4/20 0.52
ALDH1A1 P00352 2/20 0.52
HPGD P15428 2/20 0.52
RXFP1 Q9HBX9 1/20 0.43
KMT2A Q03164 4/20 0.42
MEN1 O00255 3/20 0.42
POLB P06746 2/20 0.42
MAP2 P11137 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.40
BLM P54132 1/20 0.40
MAPK13 O15264 2/20 0.39
MAPK12 P53778 2/20 0.39
MAPK11 Q15759 2/20 0.39
MAPK14 Q16539 2/20 0.39
PTGS1 P23219 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
TUBB4A P04350 1/20 0.39
TUBB P07437 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4872057 0.99 KDM4E (0.51) KDM4EMAPTALDH1A1HPGDRXFP1
SCHEMBL5160054 0.86 KDM4E (0.52) KDM4EMAPTALDH1A1HPGDRXFP1
Hydrochloric Acid SCHEMBL5162033 0.83 KDM4E (0.49) KDM4EMAPTALDH1A1HPGDRXFP1
Methanesulfonamide SCHEMBL5159051 0.81 KDM4E (0.48) KDM4EMAPTALDH1A1HPGDRXFP1
Methanesulfonamide SCHEMBL5176661 0.80 KDM4E (0.46) KDM4EMAPTALDH1A1HPGDRXFP1
SCHEMBL4591895 0.79 KDM4E (0.48) KDM4EMAPTALDH1A1HPGDKMT2A
SCHEMBL4592180 0.78 KDM4E (0.52) KDM4EMAPTALDH1A1HPGDRXFP1
SCHEMBL4591801 0.76 KDM4E (0.46) KDM4EMAPTALDH1A1HPGDKMT2A
SCHEMBL5160074 0.76 KDM4E (0.57) KDM4EMAPTALDH1A1HPGDRXFP1
SCHEMBL4900969 0.76 MAP2 (0.70) KDM4EMAPTALDH1A1HPGDMAP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070248672-A1 Indole and Azaindole Derivatives with Antitumor Action NIKEM RESEARCH S.R.L. (IT) 2007-10-25 US disclosed
EP-1750687-A2 INDOLE AND AZAINDOLE DERIVATIVES WITH ANTITUMOR ACTION NIKEM RESEARCH S.R.L. (IT) 2007-02-14 EP disclosed
WO-2005105213-A2 INDOLE AND AZAINDOLE DERIVATIVES WITH ANTITUMOR ACTION NIKEM RESEARCH S.R.L. (IT) 2005-11-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070248672-A1 Indole and Azaindole Derivatives with Antitumor Action IDO1, IDO2, INMT KDM4E 512/4885MAPT 4170/4885ALDH1A1 788/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.